熔点 | 107°C(lit.) |
别名 | ;['4-Bromo-α-chlorobenzylphosphonic Acid Diphenyl Ester'] |
4-溴-α-氯苄基磷酸二苯酯
Diphenyl 4-Bromo-α-chlorobenzylphosphonate (订货以英文为准)
编号:D155193
CAS号:189099-56-7
分子式:C19H15BRCLO3P
分子量:437.65
产品名称 | Diphenyl 4-Bromo-α-chlorobenzylphosphonate |
中文名称 | 4-溴-α-氯苄基磷酸二苯酯 |
CAS号 | 189099-56-7 |
MDL编码 | D155193 |
分子式(M.F.) | C19H15BRCLO3P |
分子量(M.W.) | 437.65 |
储存条件 | 充氩 |
Reaxys-RN | 1543618 |
信号词 | Danger |
危害声明 | H301 |
警示性声明 | P301 + P310 |
WGK德国 | 3 |
技术规格
Background: | Acts as part of the IKK complex in the conventional pathway of NF-kappa-B activation and phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor. As part of the non-canonical pathway of NF-kappa-B activation, the MAP3K14-activated CHUK/IKKA homodimer phosphorylates NFKB2/p100 associated with RelB, inducing its proteolytic processing to NFKB2/p52 and the formation of NF-kappa-B RelB-p52 complexes. Also phosphorylates NCOA3. Phosphorylates 'Ser-10' of histone H3 at NF-kappa-B-regulated promoters during inflammatory responses triggered by cytokines. |
Applications: | WB, IHC |
Name of antibody: | CHUK |
Immunogen: | Synthetic peptide of human CHUK (Ab-23) |
Full name: | conserved helix-loop-helix ubiquitous kinase |
Synonyms: | IKK1; IKKA; IKBKA; TCF16; NFKBIKA; IKK-alpha |
SwissProt: | O15111 |
IHC positive control: | Human colon carcinoma |
IHC Recommend dilution: | 50-100 |
WB Predicted band size: | 85 kDa |
WB Positive control: | Hela, 293 and 3T3 cells |
WB Recommended dilution: | 500-1000 |
搜索质检报告(COA)
搜索MSDS
相关产品